Featured in Hidradenitis Suppurativa
Earlier Treatment, Different Outcomes: Secukinumab and the HS Disease Course
Discover this week's featured video and expert opinion
Latest Hidradenitis Suppurativa Videos
Hidradenitis Suppurativa
WCM26 Day 2 Video Recap
Featuring James Del Rosso, DO | Andrea Murina, MD | Shawn Kwatra, MD | Dawn Merritt, DO
Hidradenitis Suppurativa
What Four Years Can Tell Us About Treating Moderate to Severe HS
Featuring Nicholas Brownstone, MD
Featured CME on Hidradenitis Suppurativa
Hidradenitis Suppurativa Episodes to Explore
Episode 146
Managing HS: What A Difference A Year Makes!
In this episode of Derms and Conditions, host James Q. Del Rosso, DO, welcomes back Michael Payette, MD, a dermatologist in private...
Episode 2
Another Cup of Tea with Dr. D? Part 2: Closing the Loop on HS
In Part Two of the Tea with Dr. D premiere, James Q. Del Rosso, DO, returns with Lauren Lam, MD, a Canadian dermatologist...
Hidradenitis Suppurativa News & Research
Adverse Events Not Increased With Multiple ITIs in Hidradenitis Suppurativa
Short- or long-term risk for adverse corticosteroid effects did not increase with multiple intramuscular triamcinolone injections
Patients With Hidradenitis Suppurativa Have Increased Risk for Self-Harm
Patients with HS have a higher hazard of suicide; those who die by suicide more often have prior self-harm episodes
Causal Effect Suggested for BMI, IBD on Hidradenitis Suppurativa
Mendelian randomization analyses support effect of BMI and IBD, with no signs of pleiotropy